These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20617152)

  • 1. A new method for the evaluation of vaccine safety based on comprehensive gene expression analysis.
    Momose H; Mizukami T; Ochiai M; Hamaguchi I; Yamaguchi K
    J Biomed Biotechnol; 2010; 2010():361841. PubMed ID: 20617152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of quantitative gene expression analysis for pertussis vaccine safety control.
    Hamaguchi I; Imai J; Momose H; Kawamura M; Mizukami T; Naito S; Maeyama J; Masumi A; Kuramitsu M; Takizawa K; Kato H; Mizutani T; Horiuchi Y; Nomura N; Watanabe S; Yamaguchi K
    Vaccine; 2008 Aug; 26(36):4686-96. PubMed ID: 18619509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics in the preclinical development of vaccines: evaluation of efficacy and systemic toxicity in the mouse using array technology.
    Regnström KJ
    Methods Mol Biol; 2008; 448():447-67. PubMed ID: 18370242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.
    Momose H; Sasaki E; Kuramitsu M; Hamaguchi I; Mizukami T
    Vaccine; 2018 Oct; 36(43):6449-6455. PubMed ID: 30243500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chipping away at the mystery of drug responses.
    Rockett JC
    Pharmacogenomics J; 2001; 1(3):161-3. PubMed ID: 11908748
    [No Abstract]   [Full Text] [Related]  

  • 6. [New evaluation methods of vaccine safety].
    Hamaguchi I; Yamaguchi K
    Nihon Rinsho; 2008 Oct; 66(10):1922-31. PubMed ID: 18939491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling.
    Momose H; Mizukami T; Kuramitsu M; Takizawa K; Masumi A; Araki K; Furuhata K; Yamaguchi K; Hamaguchi I
    PLoS One; 2015; 10(4):e0124392. PubMed ID: 25909814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain on a chip: a method to detect novel neuroprotective candidate targets.
    Tang Y; Bernaudin M
    Methods Mol Biol; 2007; 399():153-66. PubMed ID: 18309931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation.
    Mizukami T; Imai J; Hamaguchi I; Kawamura M; Momose H; Naito S; Maeyama J; Masumi A; Kuramitsu M; Takizawa K; Nomura N; Watanabe S; Yamaguchi K
    Vaccine; 2008 Apr; 26(18):2270-83. PubMed ID: 18374459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust cluster analysis of microarray gene expression data with the number of clusters determined biologically.
    Bickel DR
    Bioinformatics; 2003 May; 19(7):818-24. PubMed ID: 12724291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays.
    Gerhold D; Lu M; Xu J; Austin C; Caskey CT; Rushmore T
    Physiol Genomics; 2001 Apr; 5(4):161-70. PubMed ID: 11328961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in microarray class discovery: a comprehensive examination of normalization, gene selection and clustering.
    Freyhult E; Landfors M; Önskog J; Hvidsten TR; Rydén P
    BMC Bioinformatics; 2010 Oct; 11():503. PubMed ID: 20937082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptable levels of endotoxin in vaccine formulations during preclinical research.
    Brito LA; Singh M
    J Pharm Sci; 2011 Jan; 100(1):34-7. PubMed ID: 20575063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarrays in drug discovery.
    Sauter G; Simon R; Hillan K
    Nat Rev Drug Discov; 2003 Dec; 2(12):962-72. PubMed ID: 14654795
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines, Geneva, Switzerland, 7-8 April 2005.
    Shin J; Wood D; Robertson J; Minor P; Peden K;
    Biologicals; 2007 Mar; 35(1):63-71. PubMed ID: 17321940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond clustering of array expressions.
    Loganantharaj R
    Int J Bioinform Res Appl; 2009; 5(3):329-48. PubMed ID: 19525204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression microarrays: a 21st century tool for directed vaccine design.
    Dhiman N; Bonilla R; O'Kane DJ; Poland GA
    Vaccine; 2001 Oct; 20(1-2):22-30. PubMed ID: 11567742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-automated clustering of gene expression data sets.
    Kim M; Jung HY; Chung M; Kim P; Park SH; Park SJ
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():4625-8. PubMed ID: 18003036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing, testing, and validating a microarray for stem cell characterization.
    Luo Y; Bhattacharya B; Yang AX; Puri RK; Rao MS
    Methods Mol Biol; 2006; 331():241-66. PubMed ID: 16881521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.